Catalogo dei prodotti della ricerca

Marampon, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.076
EU - Europa 1.691
AS - Asia 1.216
SA - Sud America 103
AF - Africa 20
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.110
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.016
IT - Italia 753
SG - Singapore 702
SE - Svezia 255
IN - India 201
CN - Cina 165
RU - Federazione Russa 150
DE - Germania 123
FI - Finlandia 114
ID - Indonesia 88
BR - Brasile 78
CA - Canada 44
UA - Ucraina 42
IE - Irlanda 39
FR - Francia 34
AT - Austria 31
GB - Regno Unito 31
NL - Olanda 26
RO - Romania 24
BG - Bulgaria 20
TR - Turchia 15
HK - Hong Kong 14
MX - Messico 14
BE - Belgio 12
AR - Argentina 11
CH - Svizzera 9
CL - Cile 9
TG - Togo 7
ZA - Sudafrica 7
AL - Albania 6
TW - Taiwan 5
ES - Italia 4
KR - Corea 4
LT - Lituania 4
PH - Filippine 4
AU - Australia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
PK - Pakistan 3
EC - Ecuador 2
EG - Egitto 2
IQ - Iraq 2
MY - Malesia 2
PL - Polonia 2
RS - Serbia 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
SC - Seychelles 1
TN - Tunisia 1
UY - Uruguay 1
Totale 8.110
Salva come PNG Salva come JPEG
Città #
Fairfield 894
Ashburn 419
Woodbridge 408
Singapore 349
Seattle 324
Cambridge 321
Rome 319
Houston 318
Chandler 277
Wilmington 274
Ann Arbor 161
Princeton 139
Santa Clara 120
Lawrence 105
Dearborn 104
San Paolo di Civitate 104
Jakarta 88
Plano 86
Fremont 84
Boston 70
Helsinki 70
Millbury 60
Beijing 55
San Diego 49
Dublin 39
Nuremberg 39
Moscow 37
New York 37
Cosenza 32
Milan 27
Norwalk 27
Boardman 26
Toronto 25
Falkenstein 24
Andover 23
Phoenix 22
Falls Church 20
Sofia 20
Yubileyny 18
Vienna 17
Ottawa 16
Des Moines 13
Hong Kong 13
Brussels 12
Council Bluffs 11
Nanjing 11
Frankfurt am Main 9
Hefei 9
Pescara 9
Federal 8
Istanbul 8
Kunming 8
London 8
Romola 8
San Severo 8
Zhengzhou 8
Bremen 7
Lomé 7
Muizenberg 7
San Mateo 7
Turin 7
Latina 6
Los Angeles 6
Mannheim 6
Tirana 6
Bologna 5
Bühl 5
Dallas 5
Guangzhou 5
Jacksonville 5
Lappeenranta 5
L’Aquila 5
Menlo Park 5
Montevarchi 5
Nanchang 5
Palermo 5
Termoli 5
Verona 5
Zurich 5
Amsterdam 4
Hyderabad 4
Iztapalapa 4
Laurel 4
Mexico City 4
Naples 4
Sacramento 4
Shanghai 4
São Paulo 4
Villa Park 4
Ariccia 3
Bolzano 3
Brescia 3
Chengdu 3
Fuzhou 3
Jinan 3
La Jolla 3
Manassas 3
Marino 3
Munich 3
New Taipei City 3
Totale 5.992
Salva come PNG Salva come JPEG
Nome #
PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines 142
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells 106
MiR-200c-3p contrasts PD-L1 induction by combinatorial therapies and slows proliferation of epithelial ovarian cancer through downregulation of β-Catenin and c-Myc 105
Successful role of adjuvant radiotherapy in a rare case of tracheal inflammatory myofibroblastic tumor: a case report 104
DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation 101
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 99
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population 95
Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells 93
Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results 93
Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study 92
ROCK2 and its alternatively spliced isoform ROCK2m positively control the maturation of the myogenic program 92
c-Myc sustains transformed phenotype and promotes radioresistance of embryonal rhabdomyosarcoma cell lines 91
A feasibility study of percutaneous radiofrequency ablation followed by radiotherapy in the management of painful osteolytic bone metastases 91
Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization 91
Deep seated tumour treatments with electrons of high energy delivered at FLASH rates: the example of prostate cancer 91
Radiation therapy and serum salivary amylase in head and neck cancer 89
Antitumor effects of carnertinib in castration resistant prostate cancer models: A Comparative study with erlotinib. 87
Can radiotherapy be combined with radiofrequency ablation in the management of symptomatic osteolytic skeletal metastasis? 87
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 86
A Feasibility Study of Percutaneous Radiofrequency Ablation with Radiotherapy in Painful Osteolytic Bone Metastases 83
BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells 83
Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models 82
5-Azacitidine Restores and Amplifies the Bicalutamide Response on Preclinical Models of Androgen Receptor Expressing or Deficient Prostate Tumors 82
Comparative study of testosterone and vitamin D analogue, elocalcitol, on insulin-controlled signal transduction pathway regulation in human skeletal muscle cells 81
Bone control of muscle function 80
Defective DNA repair mechanisms in prostate cancer: impact of olaparib 79
5-azacitidine restores and amplifies the response to bicalutamide and radiotherapy on preclinical models of androgen receptor expressing or deficient prostate tumors 79
Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis 79
Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines 79
MEK/ERK Inhibition by U0126 Radiosensitizes Rhabdomyosarcoma Cells In Vitro and In Vivo 78
The small molecule ephrin receptor inhibitor, GLPG1790, Reduces renewal capabilities of cancer stem cells, showing anti-tumour efficacy on preclinical glioblastoma models 77
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 77
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo 76
Immune check-point in glioblastoma multiforme 76
Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation 74
Cellular and molecular mediators of bone metastatic lesions 73
Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay 73
Hypofractionated intensity-modulated radiotherapy in locally advanced unresectable pancreatic cancer: a pilot study 73
OTX015 epi‐drug exerts antitumor effects in ovarian cancer cells by blocking GNL3‐mediated radioresistance mechanisms: cellular, molecular and computational evidence 73
Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 72
HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers 72
Dnmt3a and dnmt3b targeting as an effective radiosensitizing strategy in embryonal rhabdomyosarcoma 72
null 71
The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells 70
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance 70
MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells In vitro and In vivo by Downregulating Growth and DNA Repair Signals 69
Adjuvant vaginal interventional radiotherapy in early-stage non-endometrioid carcinoma of corpus uteri: a systematic review 69
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma 68
Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines 68
Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy 67
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 67
Nerve growth factor regulation of cyclin D1 in PC12 cells through a p21 RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-κB 66
MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma 66
Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells 66
ATX-101, a peptide targeting PCNA, has antitumor efficacy alone or in combination with radiotherapy in murine models of human glioblastoma 66
Episode-like pulse testosterone supplementation induces tumor senescence and growth arrest down-modulating androgen receptor through modulation of p-ERK1/2, pAR ser81 and CDK1 signaling: biological implications for men treated with testosterone replacement therapy 65
The impact of conventional or hypofractionated radiotherapy on voice quality and oncological outcome in patients with early glottic cancer 64
Treatment of solitary painful osseous metastases with radiotherapy, cryoablation or combined therapy: propensity matching analysis in 175 patients 63
Treatment of osteolytic solitary painful osseous metastases with radiofrequency ablation or cryoablation: a retrospective study by propensity analysis 63
Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors 63
p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and oncophenotype reversion in rhabdomyosarcoma cells 62
Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis 62
The role of vaginal brachytherapy in stage I endometrial serous cancer. a systematic review 62
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties 62
MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by down regulating growth and DNA repair signals 61
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage 61
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 61
The TORC1/TORC2 inhibitor, palomid 529 (P529), reduces tumor growth and sensitizes to chemotherapy and radiotherapy aggressive hormone refractory prostate cancer cells both in vitro and in vivo 60
The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models 60
The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study 60
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 60
Antitumorigenic effects of inhibiting ephrin receptor kinase signaling by GLPG1790 against colorectal cancer cell lines In vitro and In vivo 60
Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines 59
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models 59
The brain penetrating and dual TORC1/TORC2 inhibitor, RES529, elicits anti-glioma activity and enhances the therapeutic effects of anti-angiogenetic compounds in preclinical murine models 59
Phosphodiesterase type-5 inhibitor tadalafil modulates steroid hormones signaling in a prostate cancer cell line 59
Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models 58
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 58
Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer 58
Hormonal Therapy Promotes Hormone-Resistant Phenotype by Increasing DNMT Activity and Expression in Prostate Cancer Models 58
Locally advanced rectal cancer. Treatment approach in elderly patients 57
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 56
HORMONAL THERAPY PROMOTES HORMONE-RESISTANT PHENOTYPE BY INCREASING DNMT ACTIVITY AND EXPRESSION IN PROSTATE CANCER MODELS 56
Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples 56
Histone deacetylase inhibitor Belinostat (PXD-101) represses androgen receptor expression and acts synergistically with castration and bicalutamide treatment to inhibit prostate cancer growth hormone refractory models 55
Distinctive binding properties of the negative allosteric modulator, [3H]SB269,652, at recombinant dopamine D3 receptors 54
One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients 54
The chemokine receptor CXCR7 is highly expressed in bone metastatic lesions of human prostate cancer and mediates tumor cell growth and invasiveness in preclinical models 53
Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer 53
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis 53
Abstract 6307: The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, augments the antitumor efficacy of radiotherapy in treatment of human glioblastoma 52
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer 52
The first negative allosteric modulator for dopamine D2 and D3 receptors, SB269652 may lead to a new generation of antipsychotic drugs 52
Definitive weekly hypofractionated radiotherapy in surgery-ineligible older adults with cutaneous squamous cell carcinoma of the head and neck region 51
Intravesical instillations with polydeoxyribonucleotides reduce symptoms of radiation-induced cystitis in patients treated with radiotherapy for pelvic cancer: a pilot study 51
Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models 51
Abscopal effect on bone metastases from solid tumors: a systematic review and retrospective analysis of challenge within a challenge 50
Clinical efficacy of adjuvant radiotherapy for WHO grade II intracranial meningioma 49
Neurotoxic and neuroprotective role of exosomes in parkinson’s disease 49
null 47
Totale 7.059
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.122
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020499 0 0 0 0 0 0 0 0 200 133 98 68
2020/2021732 81 87 59 29 15 98 9 32 103 127 61 31
2021/20221.265 24 72 118 38 190 41 53 145 79 70 225 210
2022/20231.249 241 293 75 124 102 125 19 70 118 11 44 27
2023/2024770 45 80 33 54 88 91 24 63 14 87 84 107
2024/20251.794 27 116 205 206 177 233 221 182 427 0 0 0
Totale 8.724